EU conference participants visit SciLifeLab to discuss precision medicine

During the visit, Jenny Alfredsson, Head of Operations at SciLifeLab; Anna Lyander, Head of Unit at the Clinical Genomics Stockholm unit; and others talked about how SciLifeLab plays a vital role in progressing precision medicine from research to implementation.

The Presidency of the Council of the European Union rotates among the Member States every six months. Currently, Sweden holds the Presidency. As part of this, the conference Life Sciences – The Era of Personalised Medicine took place in Stockholm on June 26-27. The conference highlighted life sciences, with the aim of taking the next steps in the development and organization of personalized medicine.

During the conference, attendants visited SciLifeLab to learn more about how we play a vital role in progressing precision medicine from research to implementation. The focus of the visit was on clinical genomics and data as the core of precision medicine.

Jenny Alfredsson, Head of Operations at SciLifeLab, talked about how SciLifeLab uses strategic and operational planning, financial management and decision-making to provide efficient and quality-driven support to the SciLifeLab management and research community.

Johan Rung, Head of Data Centre at SciLifeLab, explained how Data Centre provides cutting-edge research data services for both infrastructure units and the life science research community, with a strong international collaboration network.

The SciLifeLab and Wallenberg National Program for Data-driven Life Science (DDLS), is a 12-year initiative funded with a total of SEK 3.1 billion from the Knut and Alice Wallenberg Foundation. The purpose of the program is to train and recruit the next generation of life scientists, to create a strong computational and data science base, and to strengthen the competencies in today’s research society. Heidi Törmänen Persson, Collaboration Manager at SciLifeLab and Coordinator of DDLS, discussed the DDLS program with the visitors.

Valtteri Wirta, Platform Scientific Director at the Clinical Genomics Stockholm Unit at SciLifeLab and Head of the Genomic Medicine Center Karolinska at Karolinska University Hospital, talked about how his team facilitates the transition of genomics technologies, especially massively parallel DNA sequencing, into diagnostic use in several disease areas.

Anna Lyander, Head of Unit at the Clinical Genomics Stockholm Unit at SciLifeLab, talked about her work in bringing precision diagnostics to patients by transferring genomics technologies from academia to Swedish health care.
Learn more about the Life Sciences – The Era of Personalised Medicine conference.